↓ Skip to main content

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data

Overview of attention for article published in BMC Infectious Diseases, August 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data
Published in
BMC Infectious Diseases, August 2012
DOI 10.1186/1471-2334-12-175
Pubmed ID
Authors

David R Strutton, Raymond A Farkouh, Jaime L Rubin, Lisa J McGarry, Paul M Loiacono, Keith P Klugman, Steven I Pelton, Kristen E Gilmore, Milton C Weinstein

Abstract

Analysis of US claims data from April 2010 to June 2011 estimated that 39% of the 13-valent pneumococcal conjugate vaccine (PCV13) catch-up eligible cohort would ever receive the catch-up vaccination; a previous analysis assumed 87%.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Student > Bachelor 4 22%
Student > Ph. D. Student 3 17%
Professor 1 6%
Student > Doctoral Student 1 6%
Other 3 17%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 9 50%
Nursing and Health Professions 2 11%
Economics, Econometrics and Finance 1 6%
Agricultural and Biological Sciences 1 6%
Psychology 1 6%
Other 2 11%
Unknown 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2012.
All research outputs
#10,995,507
of 12,373,180 outputs
Outputs from BMC Infectious Diseases
#3,969
of 4,592 outputs
Outputs of similar age
#104,768
of 122,076 outputs
Outputs of similar age from BMC Infectious Diseases
#45
of 45 outputs
Altmetric has tracked 12,373,180 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,592 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,076 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.